Research over the past decade has confirmed that epigenetic alterations act in concert with genetic lesions to deregulate gene expression in acute myeloid leukemia and myelodysplastic syndromes. Epigenetic alterations may serve as markers of disease. and may potentially be used for classification. prognostication and to monitor minimal residual disease. https://ashleyshomestores.shop/product-category/accessory-set-of-5/